HIGHLIGHTS
- who: Jung Su Ryu and collaborators from the Department of Cell and Molecular Biology, University of Mississippi Medical Center have published the paper: Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study, in the Journal: (JOURNAL) of 23/Dec/2020
- what: These unwanted side effects are usually a dose-limiting factor for chemotherapy and are a main reason for the unsatisfactory prognosis of the therapy. The authors report the potential use of this strategy, an MMP-responsive ELP drug Dox . This study demonstrated that the while the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.